Oncology Drug Services
-
Manufactured by Sengenicsbased in USA
Rapidly screen promising immuno-oncology targets; Sengenics helps accelerate oncology drug discovery with fast and efficient screening of immunotherapy drug ...
-
based in USA
and optimized to interrogate the responses of your immuno-oncology drugs in only 4 days using primary patient specimens. ...
-
based in USA
CureMatch provides a scored and ranked listing of the most well-adapted personalized medicine treatment options. The comprehensive analysis considers commonly used treatments, as well as targeted therapy, immunotherapy, hormone therapy, and newly approved oncology drugs. These options are presented either alone (monotherapy) or in ...
-
based in USA
platform developed and optimized to interrogate the responses of your Immuno-Oncology drugs with a tumor-specific microenvironment in only 4 days using PDX-O (patient-derived xenograft organoids) collected with matched, autologous TIL ...
-
based in USA
Champions Oncology is transforming drug discovery and development through our integrated scientific approach. Our expert team works to improve cancer outcomes each day for our research partners and ultimately patients across the ...
-
by Natera, Inc.based in USA
Why partner with Signatera for your clinical trial? Clinically validated across multiple solid tumors, Signatera has shown to predict relapse in >98% of patients without further treatment. Experienced team with Global reach: CE Mark, three FDA Breakthrough Device Designations, 8 Non-Significant Risk (NSR) determinations. >60 Natera IP assets covering ctDNA MRD and ...
-
based in USA
Champions' Discovery Services leverages the Lumin Analytic Engine and rapid validation workflows to identify novel therapeutic targets and/or biomarkers of ...
-
Manufactured by Piramal Pharma Solutions (PPS)based in INDIA
We offer pharmaceutical development services for oral solids, liquids, creams, ointment and sterile injectable from our facilities in US, UK and India. As a leader in integrated solutions, we seamlessly engage our global sites to conduct development work in parallel; accelerating time to market and reduce costs for our ...
-
based in UNITED KINGDOM
Viewing cancer through the immune lens (immuno-oncology) has led to the most promising advancements in cancer treatment in recent history, nonetheless the full potential of the approach is as yet ...
-
Manufactured by XILIS, Inc.based in USA
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, higher-throughput, and greater cost savings, as well as more predictive and accurate results. MOS ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you